300 related articles for article (PubMed ID: 24441388)
61. Extra-renal elimination of uric acid via intestinal efflux transporter BCRP/ABCG2.
Hosomi A; Nakanishi T; Fujita T; Tamai I
PLoS One; 2012; 7(2):e30456. PubMed ID: 22348008
[TBL] [Abstract][Full Text] [Related]
62. A 'complexity' of urate transporters.
Wright AF; Rudan I; Hastie ND; Campbell H
Kidney Int; 2010 Sep; 78(5):446-52. PubMed ID: 20613716
[TBL] [Abstract][Full Text] [Related]
63. [Dynamics of uric acid metabolism in hyperuricemia].
Nakamura T; Takagi K; Ueda T
Nihon Rinsho; 1996 Dec; 54(12):3230-6. PubMed ID: 8976097
[TBL] [Abstract][Full Text] [Related]
64. Hyperuricemia enhances intracellular urate accumulation via down-regulation of cell-surface BCRP/ABCG2 expression in vascular endothelial cells.
Komori H; Yamada K; Tamai I
Biochim Biophys Acta Biomembr; 2018 May; 1860(5):973-980. PubMed ID: 29317200
[TBL] [Abstract][Full Text] [Related]
65. Tubular urate transporter gene polymorphisms differentiate patients with gout who have normal and decreased urinary uric acid excretion.
Torres RJ; de Miguel E; Bailén R; Banegas JR; Puig JG
J Rheumatol; 2014 Sep; 41(9):1863-70. PubMed ID: 25128519
[TBL] [Abstract][Full Text] [Related]
66. Intestinal uric acid excretion contributes to serum uric acid decrease during acute gout attack.
Zhao T; Cao L; Lin C; Xu R; Du X; Zhou M; Yang X; Wan W; Zou H; Zhu X
Rheumatology (Oxford); 2023 Dec; 62(12):3984-3992. PubMed ID: 37042723
[TBL] [Abstract][Full Text] [Related]
67. Functional polymorphisms of the ABCG2 gene are associated with gout disease in the Chinese Han male population.
Zhou D; Liu Y; Zhang X; Gu X; Wang H; Luo X; Zhang J; Zou H; Guan M
Int J Mol Sci; 2014 May; 15(5):9149-59. PubMed ID: 24857923
[TBL] [Abstract][Full Text] [Related]
68. Uric acid transporter ABCG2 is increased in the intestine of the 5/6 nephrectomy rat model of chronic kidney disease.
Yano H; Tamura Y; Kobayashi K; Tanemoto M; Uchida S
Clin Exp Nephrol; 2014 Feb; 18(1):50-5. PubMed ID: 23584883
[TBL] [Abstract][Full Text] [Related]
69. Polymorphisms of
Duong NT; Ngoc NT; Thang NTM; Phuong BTH; Nga NT; Tinh ND; Quynh DH; Ton ND; Hai NV
Medicina (Kaunas); 2019 Jan; 55(1):. PubMed ID: 30621105
[No Abstract] [Full Text] [Related]
70. Uricosuric drugs: the once and future therapy for hyperuricemia?
Bach MH; Simkin PA
Curr Opin Rheumatol; 2014 Mar; 26(2):169-75. PubMed ID: 24445479
[TBL] [Abstract][Full Text] [Related]
71. A common variant of organic anion transporter 4 (OAT4/SLC22A11) gene is associated with renal underexcretion type gout.
Sakiyama M; Matsuo H; Shimizu S; Nakashima H; Nakayama A; Chiba T; Naito M; Takada T; Suzuki H; Hamajima N; Ichida K; Shimizu T; Shinomiya N
Drug Metab Pharmacokinet; 2014; 29(2):208-10. PubMed ID: 24025986
[TBL] [Abstract][Full Text] [Related]
72. Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2.
Toyoda Y; Pavelcová K; Klein M; Suzuki H; Takada T; Stiburkova B
Arthritis Res Ther; 2019 Oct; 21(1):219. PubMed ID: 31661014
[No Abstract] [Full Text] [Related]
73. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
Taniguchi T; Ashizawa N; Matsumoto K; Saito R; Motoki K; Sakai M; Chikamatsu N; Hagihara C; Hashiba M; Iwanaga T
J Pharmacol Exp Ther; 2019 Oct; 371(1):162-170. PubMed ID: 31371478
[TBL] [Abstract][Full Text] [Related]
74. Mangiferin promotes intestinal elimination of uric acid by modulating intestinal transporters.
Li Q; Lin H; Niu Y; Liu Y; Wang Z; Song L; Gao L; Li L
Eur J Pharmacol; 2020 Dec; 888():173490. PubMed ID: 32827538
[TBL] [Abstract][Full Text] [Related]
75. Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension.
Campo C; Ruilope LM; Segura J; Rodicio JL; García-Robles R; Garcia-Puig J
Blood Press; 2003; 12(5-6):277-83. PubMed ID: 14763658
[TBL] [Abstract][Full Text] [Related]
76. Genome-wide meta-analysis between renal overload type and renal underexcretion type of clinically defined gout in Japanese populations.
Toyoda Y; Nakayama A; Nakatochi M; Kawamura Y; Nakaoka H; Yamamoto K; Shimizu S; Ooyama H; Ooyama K; Shimizu T; Nagase M; Hidaka Y; Ichida K; Inoue I; Shinomiya N; Matsuo H;
Mol Genet Metab; 2022 Jul; 136(3):186-189. PubMed ID: 35148957
[TBL] [Abstract][Full Text] [Related]
77. Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway.
Chen M; Lu X; Lu C; Shen N; Jiang Y; Chen M; Wu H
Arthritis Res Ther; 2018 Feb; 20(1):20. PubMed ID: 29415757
[TBL] [Abstract][Full Text] [Related]
78. Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway.
Liu L; Zhao T; Shan L; Cao L; Zhu X; Xue Y
Nutr Metab (Lond); 2021 Jun; 18(1):63. PubMed ID: 34144706
[TBL] [Abstract][Full Text] [Related]
79. Genetic background of uric acid metabolism in a patient with severe chronic tophaceous gout.
Petru L; Pavelcova K; Sebesta I; Stiburkova B
Clin Chim Acta; 2016 Sep; 460():46-9. PubMed ID: 27288985
[TBL] [Abstract][Full Text] [Related]
80. Olsalazine Sodium Increases Renal Urate Excretion by Modulating Urate Transporters in Hyperuricemic Animals.
Niu Y; Yang P; Li H; Li Q; Lin H; Gao L; Li L
Biol Pharm Bull; 2020 Nov; 43(11):1653-1659. PubMed ID: 32863294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
